CANTON STRATEGIC HOLDINGS INC (CNTN)
Health Care · Digital asset treasury management and blockchain infrastructure; clinical-stage biotechnology · NASDAQ
A publicly traded digital asset treasury and blockchain infrastructure company that holds Canton Coin and operates validator nodes on the Canton Network, with legacy clinical-stage biotech research programs.
What CANTON STRATEGIC HOLDINGS INC does
Canton Strategic Holdings operates as the first publicly traded company focused on the Canton Network blockchain ecosystem, holding Canton Coin (CC) as a strategic digital asset reserve and operating as a Super Validator on the Canton Network to earn protocol-based rewards. The company pursues a digital asset treasury strategy that includes validator operations, investments in Canton Network applications and middleware, ecosystem collaboration, and capital-efficient token management through locking and lending programs. Additionally, the company maintains clinical-stage biotech research and development programs focused on inflammatory and immunologic conditions, though it shifted strategic priority away from biotech toward digital asset management in November 2025.
Themes: Digital asset treasury management, Blockchain infrastructure / Canton Network, Cryptocurrency / crypto ecosystem, Validator operations and protocol rewards, Institutional blockchain adoption, Clinical-stage biotech / inflammatory conditions, Capital markets digitization, Token-linked yield and DeFi strategies
Fundamentals
- Price$2.14 as of 2026-08-24 close
- Market cap$171M as of 2026-08-24
- 1-year return-54.7% 2025-08-22 close $4.72 → 2026-08-24 close $2.14
- P/En/a earnings data not available
- ROE-36.9% as of 2026-08-24
- Debt / equity0.00 as of 2026-08-24
- Beta0.92 as of 2026-08-24
- Last reported earnings2026-08-14 SEC EDGAR Form 8-K (Item 2.02)
How CNTN compares in its sector
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How CANTON STRATEGIC HOLDINGS INC looks technically
CANTON STRATEGIC HOLDINGS INC (CNTN) is trading 31.7% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed below its 200-day average about 62 trading days ago — a "death cross", a bearish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 23 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 51, neither overbought (above 70) nor oversold (below 30). It made a new 20-day high about 3 trading days ago. It is 76.4% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 31.7% below its 200-day average, the long-term trend line — a long-term downtrend | -31.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $2.39 | $2.39 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $3.13 | $3.13 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing low 24 calendar days ago — the swings before that are what the structure reading is measured on | 24 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that downward direction; the labelling fails if price closes above 2.14. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible downward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed below its 200-day average about 62 trading days ago — a "death cross", a bearish long-term signal | 62 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 23 (a reading of 25+ marks a strong trend) | 22.7 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 51, neither overbought (above 70) nor oversold (below 30) | 51.1 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($1.79 to $2.28) — its "stochastic" reading is 71 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 71.4 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 15 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $9.08 | $9.08 |
|---|---|---|
| From the 52-week high | it is 76.4% below its 52-week high (its highest price of the past year) | -76.4% |
| Above the 52-week low | it is 22.3% above its 52-week low (its lowest price of the past year) | +22.3% |
| Below the 52-week high | it is 76.4% below its highest point of the past year | 76.4% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day low about 18 trading days ago | 18 sessions |
| All-time high | its highest closing price on record is $1590.00 (set on 2022-02-02) | $1590.00 |
| Given back of the 52-week move | over the past year its closes ranged ($1.85 to $7.71), and it has recovered only a small part of its fall from last year’s high — 5% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $5.47 to $5.66. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 5.0% |
| From the all-time high | it is 99.9% below its all-time high | -99.9% |
| Nearest price level | it is trading 2.5% below a resistance level at $2.19 — a price it turned at three times since 2025-01-23, most recently on 2025-12-18. Since 2024-08-26 it has 5 such levels below the current price and 10 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +2.5% |
| All-time low | its lowest closing price on record is $0.952 (set on 2025-04-07) | $0.952 |
| Above the all-time low | it is 124.8% above its all-time low | +124.8% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 79% of it) | 21st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.154 between its high and its low — about 7.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.154 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $1.77 and $2.19 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $1.77 – $1.98 – $2.19 |
| Typical daily range (% of price) | its price moves about 7.2% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 7.2% |
| Stretch from the 200-day average | it is trading 6.4 daily ranges below its 200-day average price (31.7% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.4 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.54× |
|---|
Candlestick patterns
2
| Since a bullish engulfing | 6 sessions ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 6 sessions ago |
|---|---|---|
| Since a bearish engulfing | 1 session ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 1 session ago |
Price gaps
2
| Gap at the open | it opened on 2026-08-24 3.2% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +3.2% |
|---|---|---|
| Gap filled | a 3.2% gap up opened on 2026-08-24 has been "filled" today — price traded back through the level the gap left behind, and it closed again during the very session that opened it | today |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -3.17% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 0.5 percentage points (the stock gained 3.9% while the market gained 3.4%) | +0.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 41.6 percentage points (the stock lost 39.2% while the market gained 2.4%) | -41.6% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 65.6 percentage points (the stock lost 54.6% while the market gained 11.1%) | -65.6% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 73.0 percentage points (the stock lost 54.7% while the market gained 18.3%) | -73.0% |
Signal agreement
2
| Bullish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive — these describe past price behaviour, not a forecast | 2 of 9 |
|---|---|---|
| Bearish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 22% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 11.6% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -22.5% |
|---|
Volume-weighted price
1
| Vs this year’s average price paid | the price is 36% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $3.36 — a volume-weighted average of daily closes over 160 sessions, not a true tick-by-tick VWAP. | -36.3% |
|---|
Price levels it has turned at before
CNTN last closed at $2.14 on 2026-08-24. Since 2024-08-26 it has turned at 5 prices below its last close and 10 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $2.19 | Resistance | 2.5% above the last close | turned there three times · 2025-01-23 to 2025-12-18 |
| $2.26 | Resistance | 5.6% above the last close | turned there twice · 2024-09-25 to 2024-12-24 |
| $2.01 | Support | 6.1% below the last close | turned there twice · 2024-11-29 to 2024-12-27 |
| $1.85 | Support | 13.6% below the last close | turned there four times · 2024-10-07 to 2025-01-14 |
| $1.68 | Support | 21.3% below the last close | turned there twice · 2025-03-24 to 2025-06-10 |
| $2.70 | Resistance | 26.2% above the last close | turned there four times · 2024-10-17 to 2026-01-21 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes above $2.14.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $2.14 and $2.23 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close below $1.75.
This reading has stood for 1 trading day, since 2026-08-24.
Read from daily closes as of 2026-08-24.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · Broke out to a new 20-day high · lagging the market · Gapped up at the open (3%+) · Most volatile (6%+ typical daily range) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-24. Describes past price behavior only — informational, not financial advice.
Key risks (from latest filing)
["Highly volatile price fluctuation of Canton Coin and cryptocurrency markets, with stock price potentially highly correlated to digital asset holdings, creating significant valuation risk","Regulatory uncertainty regarding cryptocurrencies, blockchain, and digital assets, including inability to obtain necessary regulatory approvals for biotech product commercialization","Dependence on third parties for operations, network adoption, and successful execution of validator and investment strategy; Canton Network adoption risk and competitive pressure from alternative blockchain platforms"]
What changed in the latest 10-Q
AI-assisted comparison of CNTN's 10-Q filed 2026-05-13 against the prior one filed 2025-11-12.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-13) states company began strategic shift in November 2025 to prioritize digital asset treasury management and investment in Canton Network
- Newer filing (2026-05-13) describes completed private placement offering in November 2025 and registered direct offering in January 2026
- Newer filing (2026-05-13) describes digital asset treasury strategy centered on acquiring, holding and deploying CC and supporting Canton Network through validator operations
- Newer filing (2026-05-13) identifies two reportable segments: legacy biotechnology operations and digital asset treasury strategy
- Newer filing (2026-05-13) adds new line item 'Unrealized Loss from Digital Asset Holdings' describing fair value changes in digital assets using USD/CC reference price
- Newer filing (2026-05-13) updates general and administrative expenses language to include 'expenses related to our canton-centric digital asset treasury strategy'
- Newer filing (2026-05-13) updates expectation language for general and administrative expenses to state they 'will increase in the future as we increase our personnel headcount to support our digital asset treasury strategy'
- Newer filing (2026-05-13) provides three months ended March 31, 2026 and 2025 comparative operating data showing R&D expenses of $267,823 vs $594,070 and G&A expenses of $36,600,488 vs $1,952,599
- Removed:
- Older filing (2025-11-12) referred to company as 'Tharimmune, Inc.' whereas newer filing (2026-05-13) refers to 'Canton Strategic Holdings, Inc.'
- Older filing (2025-11-12) contained detailed Overview describing Tharimmune as clinical-stage biotechnology company with product candidates TH104, TH103, INT-023/TH023 and pipeline programs in immuno-oncology
- Older filing (2025-11-12) contained Recent Developments section describing warrant amendments, related party payments, compensatory arrangements, and board/management changes from October-November 2025
- Reworded:
- Reference to Form 10-K year changed from 'December 31, 2024' (older) to 'December 31, 2025' (newer)
- Company description changed from 'clinical-stage biotechnology company developing therapeutic candidates in immunology and inflammation conditions' (older) to focus on 'digital asset treasury management and investment in the digital asset ecosystem' (newer)
- Older filing emphasized biotechnology operations from 2022-2025; newer filing states this was shifted in November 2025 to prioritize digital asset strategy
- Notes:
- Newer filing text appears truncated at end of financial data table ('Oth') so full comparison of results of operations section not possible
- Substantial company strategy and identity change evident between filings, suggesting potential material corporate transition rather than incremental operational update
Risk Factors
- Added:
- Added 'ITEM 4. MINE SAFETY DISCLOSURES' to table of contents (filed 2026-05-13)
- Added forward-looking statement regarding 'the adoption of a digital asset treasury' (filed 2026-05-13)
- Added forward-looking statement regarding 'fluctuations in the market price of Canton Coin' (filed 2026-05-13)
- Added forward-looking statement regarding 'our ability to build commercial infrastructure' (filed 2026-05-13)
- Added forward-looking statement regarding 'failure to realize the anticipated benefits of the digital asset treasury strategy' (filed 2026-05-13)
- Added forward-looking statement regarding 'the risk that the price of our common stock may be highly correlated to the price of the digital assets that we hold' (filed 2026-05-13)
- Added forward-looking statement regarding 'our ability to operate as a Super Validator and run additional Validators on the Canton Network' (filed 2026-05-13)
- Company name changed to 'CANTON STRATEGIC HOLDINGS, INC.' in balance sheet (filed 2026-05-13)
- Balance sheet dates changed to 'March 31, 2026' and 'December 31, 2025' (filed 2026-05-13)
- Digital assets line item added to balance sheet showing $541,569,363 and $501,760,369 (filed 2026-05-13)
- Deferred tax liability line item added showing $113,713,951 and $117,934,191 (filed 2026-05-13)
- Outstanding shares increased from 37,112,220 to 56,656,271 (filed 2026-05-13)
- Removed:
- Removed 'ITEM 5. OTHER INFORMATION' page number reference (changed from page 18 to page 10) (filed 2025-11-12)
- Removed forward-looking statement regarding 'our need to raise substantial additional capital to fund our operation' (filed 2025-11-12)
- Removed forward-looking statement regarding 'our dependence on third parties in the conduct of our clinical trials' (filed 2025-11-12)
- Removed forward-looking statement regarding 'the impact of a health epidemic on our business, our clinical trials, our research programs, healthcare systems, or the global economy as a whole' (filed 2025-11-12)
- Removed forward-looking statement regarding 'the potential that results of pre-clinical and clinical trials indicate our current product candidates or any future product candidates we may seek to develop are unsafe or ineffective' (filed 2025-11-12)
- Removed forward-looking statement regarding 'the possibility that a third party may claim we or our third-party licensors have infringed, misappropriated or otherwise violated their intellectual property rights' (filed 2025-11-12)
- Removed forward-looking statement regarding 'our reliance on third-party suppliers and manufacturers' (filed 2025-11-12)
- Removed 'THARIMMUNE, INC.' company name from balance sheet (filed 2025-11-12)
- Removed balance sheet line items for 'Deferred offering costs' (filed 2025-11-12)
- Removed balance sheet line items for 'Insurance premium financing liability' and 'Note payable' (filed 2025-11-12)
- Removed 'For the Three Months Ended September 30' and 'For the Nine Months Ended September 30' statements of operations (filed 2025-11-12)
- Reworded:
- Changed 'our ability to comply with applicable laws and obtain the necessary regulatory approvals' language (filed 2026-05-13) versus older 'our ability to obtain the necessary regulatory approvals' (filed 2025-11-12)
- Expanded regulatory language to include 'to market and commercialize our product candidates' in newer filing (filed 2026-05-13)
- Changed dependence language from 'our dependence on third parties in the conduct of our clinical trials' to 'our dependence on third parties to carry out our operations' (filed 2026-05-13)
- Notes:
- The two filings appear to reflect a significant business transformation or merger, with the older filing showing 'THARIMMUNE, INC.' (a clinical-stage biotech company) and the newer filing showing 'CANTON STRATEGIC HOLDINGS, INC.' (with substantial digital assets); the comparison reveals this structural change rather than incremental updates to the same company
- Financial statements show completely different balance sheet structures and company entities, suggesting these are not comparable period-over-period updates
- The forward-looking statements list has been substantially restructured to reflect the new business focus on digital assets and validators rather than clinical trials and pharmaceutical products
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days.
- Last 180 days0 buys · 8 sells ($343882) — 1 selling insider
Most recent open-market transaction: 2026-05-26. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about CNTN's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding CNTN as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 5,224,784
- Reported value $17,085,044
reported quarterly holdings change (2025-12-31 → 2026-03-31): 1 new, 2 increased, 0 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
CNTN had 8,497,571 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
CNTN had 10.7% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 10.35 days to cover at the same settlement.
- Reported short interest (shares) 8,497,571
- Short interest (% of shares outstanding) 10.7%
- Prior settlement (shares) 7,778,704
- Reported change 9.24%
- Days to cover (reported) 10.35
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- MicroStrategy (MSTR) - digital asset treasury company
- Coinbase (COIN) - cryptocurrency exchange and blockchain infrastructure
- Marathon Digital Holdings (MARA) - Bitcoin mining and digital assets
- Grayscale Investments - digital asset investment products
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare CNTN vs…
Frequently asked questions
What does CANTON STRATEGIC HOLDINGS INC (CNTN) do?
Canton Strategic Holdings operates as the first publicly traded company focused on the Canton Network blockchain ecosystem, holding Canton Coin (CC) as a strategic digital asset reserve and operating as a Super Validator on the Canton Network to earn protocol-based rewards. The company pursues a digital asset treasury strategy that includes validator operations, investments in Canton Network applications and middleware, ecosystem collaboration, and capital-efficient token management through…
What sector is CANTON STRATEGIC HOLDINGS INC (CNTN) in?
CANTON STRATEGIC HOLDINGS INC (CNTN) is classified in the Health Care sector. Its industry is Digital asset treasury management and blockchain infrastructure; clinical-stage biotechnology. It trades on NASDAQ.
Who are CANTON STRATEGIC HOLDINGS INC's (CNTN) competitors?
Notable peers of CANTON STRATEGIC HOLDINGS INC (CNTN) include MicroStrategy (MSTR) - digital asset treasury company, Coinbase (COIN) - cryptocurrency exchange and blockchain infrastructure, Marathon Digital Holdings (MARA) - Bitcoin mining and digital assets and Grayscale Investments - digital asset investment products. This peer set is informational only — not financial advice.
Is CANTON STRATEGIC HOLDINGS INC (CNTN) overbought or oversold right now?
CANTON STRATEGIC HOLDINGS INC (CNTN) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 51, in the neutral middle (as of 2026-08-24). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on CNTN come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.